Synlogic : Reports First Quarter 2023 Financial Results and

Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update


- Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023 -

... | May 11, 2023

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , New York , United States , Aoife Brennan , Exchange Commission , Synlogic Inc , Society For Inherited Metabolic Disorders , Nasdaq , Drug Administration , European Medicines Agency , Synlogic Reports First Quarter , Provides Business Update , Rare Pediatric , Orphan Drug Designations , Synlogic President , Chief Executive , Synthetic Biotics , Recent Business Highlights , Orphan Drug Designation , Rare Pediatric Disease Designation , Inherited Metabolic Disorders , Synthetic Biotic , Industry Conference Participation , Jefferies Global Healthcare Conference , Ginkgo Bioworks , Private Securities Litigation Reform Act , Synlogic , Nc Stock Exchange , News , Information , Press Release , Reports , First , Quarter , 023 , Financial , Results , End , Rovides , Business , Phenylketonuria , Program , N , Track , Or , Hase , , Trial , Initiation , Calf , F , 023 Sybx Us87166l1008 ,